KEMERICK TAKANG: Open Payments
NPI 1588284251 · SAN DIMAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$365 in 18 payments from 6 companies in 2025. Trend: 2023 $280 · 2024 $717 · 2025 $365
Food & beverage: $365
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $176 |
| E.R. Squibb & Sons, L.L.C. | 2 | $105 |
| Lundbeck LLC | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: VRAYLAR, COBENFY, REXULTI, HETLIOZ, ABILIFY ASIMTUFII, Auvelity.
Industry payments across CA — which companies pay providers there.
